MIST: Milestone Pharmaceuticals Inc. - Summary | Jitta

Milestone Pharmaceuticals Inc.

NASDAQ:MIST

Price
$1.41
Loss Chance
59.1%
0.33JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (11)
Recent Business Performance (28)
Financial Strength (26)
Return to Shareholders (0)
Competitive Advantage (16)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Cash Conversion CycleLess than 30 days
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.33
100.00%
3.06
96.59%
3.06
206.98%
Pharmaceuticals
4.95
53.41%
5.05
79.98%
5.69
90.19%
COMPANY DESCRIPTION
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.